The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
Frequently Asked Questions
What is Market Cap of Medicines Co?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medicines Co market cap is N/A.
What is the 52-week high for Medicines Co?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medicines Co 52 week high is N/A as of September 16, 2025.
What is the 52-week low for Medicines Co?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medicines Co 52 week low is N/A as of September 16, 2025.
What was Medicines Co stock price yesterday?
Medicines Co stock price yesterday was $84.90.
What is the PE ratio of Medicines Co?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medicines Co’s P/E ratio is None.
What is the Price-to-Book ratio of Medicines Co?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medicines Co P/B ratio is None.
What is Medicines Co's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Medicines Co's EBITDA is -26.06.
What is the 50-day moving average of Medicines Co?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medicines Co 50-day moving average is N/A.
